Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
1000+ Ergebnisse
| GW1SE5 | BioNTech SE (ADRs)/OS/Call [134]/GOLDS | - | - | 134,000 | call | BioNTech SE (ADRs) | - | 56,059 % | 0,402 | -0,017 | 3,164 | 17.09.2027 | 0,100 | Goldman Sachs | ||
| GW1SEL | BioNTech SE (ADRs)/OS/Call [134]/GOLDS | - | - | 134,000 | call | BioNTech SE (ADRs) | - | 56,415 % | 0,360 | -0,019 | 3,582 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| MK56S8 |  | BioNTech SE (ADRs)/OS/Call [134]/MS | - | - | 134,000 | call | BioNTech SE (ADRs) | - | 67,483 % | 0,274 | -0,029 | 4,615 | 18.12.2026 | 0,100 | Morgan Stanley | |
| MM8J98 | | BioNTech SE (ADRs)/OS/Call [134]/MS | - | - | 134,000 | call | BioNTech SE (ADRs) | - | 62,218 % | 0,397 | -0,022 | 3,217 | 17.06.2027 | 0,100 | Morgan Stanley | |
| MM8JVN | | BioNTech SE (ADRs)/OS/Call [134]/MS | - | - | 134,000 | call | BioNTech SE (ADRs) | - | 90,277 % | 0,197 | -0,049 | 5,866 | 18.09.2026 | 0,100 | Morgan Stanley | |
| MN0F2Y | | BioNTech SE (ADRs)/OS/Call [134]/MS | - | - | 134,000 | call | BioNTech SE (ADRs) | - | 70,540 % | 0,514 | -0,020 | 2,309 | 17.12.2027 | 0,100 | Morgan Stanley | |
| MN681L | | BioNTech SE (ADRs)/OS/Call [134]/MS | - | - | 134,000 | call | BioNTech SE (ADRs) | - | 63,112 % | 0,335 | -0,024 | 3,800 | 19.03.2027 | 0,100 | Morgan Stanley | |
| MR34X8 | | BioNTech SE (ADRs)/OS/Call [134]/MS | - | - | 134,000 | call | BioNTech SE (ADRs) | - | 82,749 % | 0,622 | -0,019 | 1,784 | 16.06.2028 | 0,100 | Morgan Stanley | |
| UP9HC6 | BioNTech SE (ADRs)/OS/Call [134]/UBS | - | - | 134,000 | call | BioNTech SE (ADRs) | - | - | - | - | - | 18.12.2026 | 0,100 | UBS | ||
| PJ8XYG | | BioNTech SE (ADRs)/OS/Call [135]/BNP | - | - | 135,000 | call | BioNTech SE (ADRs) | - | 74,619 % | 0,132 | -0,031 | 7,573 | 18.09.2026 | 0,100 | BNP Paribas | |
| PK4X40 | | BioNTech SE (ADRs)/OS/Call [135]/BNP | - | - | 135,000 | call | BioNTech SE (ADRs) | - | 51,661 % | 0,171 | -0,017 | 6,534 | 18.12.2026 | 0,100 | BNP Paribas | |
| PK55DW | | BioNTech SE (ADRs)/OS/Call [135]/BNP | - | - | 135,000 | call | BioNTech SE (ADRs) | - | 52,071 % | 0,207 | -0,018 | 5,756 | 15.01.2027 | 0,100 | BNP Paribas | |
| PM46LY | | BioNTech SE (ADRs)/OS/Call [135]/BNP | - | - | 135,000 | call | BioNTech SE (ADRs) | - | 51,186 % | 0,259 | -0,017 | 4,850 | 19.03.2027 | 0,100 | BNP Paribas | |
| DU0Q94 | BioNTech SE (ADRs)/OS/Call [135]/DZ | - | - | 135,000 | call | BioNTech SE (ADRs) | - | 78,560 % | 0,154 | -0,036 | 6,946 | 18.09.2026 | 0,100 | DZ Bank | ||
| DU0TXG | BioNTech SE (ADRs)/OS/Call [135]/DZ | - | - | 135,000 | call | BioNTech SE (ADRs) | - | 52,199 % | 0,176 | -0,017 | 6,433 | 18.12.2026 | 0,100 | DZ Bank | ||
| DU6939 | BioNTech SE (ADRs)/OS/Call [135]/DZ | - | - | 135,000 | call | BioNTech SE (ADRs) | - | 57,336 % | 0,365 | -0,019 | 3,519 | 17.06.2027 | 0,100 | DZ Bank | ||
| DU6938 | BioNTech SE (ADRs)/OS/Call [135]/DZ | - | - | 135,000 | call | BioNTech SE (ADRs) | - | 55,876 % | 0,288 | -0,020 | 4,380 | 19.03.2027 | 0,100 | DZ Bank | ||
| GW1SDM | BioNTech SE (ADRs)/OS/Call [135]/GOLDS | - | - | 135,000 | call | BioNTech SE (ADRs) | - | 56,392 % | 0,438 | -0,016 | 2,848 | 17.12.2027 | 0,100 | Goldman Sachs | ||
| GW1SDP | BioNTech SE (ADRs)/OS/Call [135]/GOLDS | - | - | 135,000 | call | BioNTech SE (ADRs) | - | 57,341 % | 0,456 | -0,016 | 2,712 | 21.01.2028 | 0,100 | Goldman Sachs | ||
| JH6MX5 | BioNTech SE (ADRs)/OS/Call [135]/JPM | - | - | 135,000 | call | BioNTech SE (ADRs) | - | 53,413 % | 0,215 | -0,019 | 5,582 | 15.01.2027 | 0,100 | JP Morgan | ||
| JE7TLW | BioNTech SE (ADRs)/OS/Call [135]/JPMD | - | - | 135,000 | call | BioNTech SE (ADRs) | - | 52,847 % | 0,181 | -0,018 | 6,325 | 18.12.2026 | 0,100 | JP Morgan | ||
| JY3LVZ | BioNTech SE (ADRs)/OS/Call [135]/JPMD | - | - | 135,000 | call | BioNTech SE (ADRs) | - | 52,062 % | 0,265 | -0,018 | 4,751 | 19.03.2027 | 0,100 | JP Morgan | ||
| MJ3R9H | | BioNTech SE (ADRs)/OS/Call [135]/MS | - | - | 135,000 | call | BioNTech SE (ADRs) | - | 67,939 % | 0,265 | -0,028 | 4,643 | 18.12.2026 | 0,100 | Morgan Stanley | |
| MK9KQ1 | | BioNTech SE (ADRs)/OS/Call [135]/MS | - | - | 135,000 | call | BioNTech SE (ADRs) | - | 56,734 % | 0,356 | -0,019 | 3,580 | 17.06.2027 | 0,100 | Morgan Stanley | |
| MM7KFV | | BioNTech SE (ADRs)/OS/Call [135]/MS | - | - | 135,000 | call | BioNTech SE (ADRs) | - | 91,262 % | 0,196 | -0,050 | 5,823 | 18.09.2026 | 0,100 | Morgan Stanley | |
| SJ7BGD | BioNTech SE (ADRs)/OS/Call [135]/SOC | - | - | 135,000 | call | BioNTech SE (ADRs) | - | 59,654 % | 0,077 | -0,016 | 10,175 | 18.09.2026 | 0,100 | Société Générale | ||
| SJ7BP7 | BioNTech SE (ADRs)/OS/Call [135]/SOC | - | - | 135,000 | call | BioNTech SE (ADRs) | - | 52,892 % | 0,181 | -0,018 | 6,321 | 18.12.2026 | 0,100 | Société Générale | ||
| SJ70X3 | BioNTech SE (ADRs)/OS/Call [135]/SOC | - | - | 135,000 | call | BioNTech SE (ADRs) | - | 53,413 % | 0,215 | -0,019 | 5,582 | 15.01.2027 | 0,100 | Société Générale | ||
| FD4113 | BioNTech SE (ADRs)/OS/Call [135]/SOC | - | - | 135,000 | call | BioNTech SE (ADRs) | - | 53,440 % | 0,436 | -0,015 | 2,893 | 21.01.2028 | 0,100 | Société Générale | ||
| FD411G | BioNTech SE (ADRs)/OS/Call [135]/SOC | - | - | 135,000 | call | BioNTech SE (ADRs) | - | 51,186 % | 0,259 | -0,017 | 4,850 | 19.03.2027 | 0,100 | Société Générale | ||
| FD411T | BioNTech SE (ADRs)/OS/Call [135]/SOC | - | - | 135,000 | call | BioNTech SE (ADRs) | - | 52,345 % | 0,330 | -0,017 | 3,904 | 17.06.2027 | 0,100 | Société Générale | ||
| UP9BRG | BioNTech SE (ADRs)/OS/Call [135]/UBS | - | - | 135,000 | call | BioNTech SE (ADRs) | - | - | - | - | - | 18.12.2026 | 0,100 | UBS | ||
| UQ64SM | BioNTech SE (ADRs)/OS/Call [135]/UBS | - | - | 135,000 | call | BioNTech SE (ADRs) | - | - | - | - | - | 18.09.2026 | 0,100 | UBS | ||
| WA416R | BioNTech SE (ADRs)/OS/Call [135]/UBS | - | - | 135,000 | call | BioNTech SE (ADRs) | - | - | - | - | - | 17.06.2027 | 0,100 | UBS | ||
| WA4ZZH | BioNTech SE (ADRs)/OS/Call [135]/UBS | - | - | 135,000 | call | BioNTech SE (ADRs) | - | - | - | - | - | 19.03.2027 | 0,100 | UBS | ||
| VH2FWS | | BioNTech SE (ADRs)/OS/Call [135]/VONT | - | - | 135,000 | call | BioNTech SE (ADRs) | - | 51,533 % | 0,203 | -0,017 | 5,837 | 15.01.2027 | 0,100 | Vontobel | |
| VJ3YTS | | BioNTech SE (ADRs)/OS/Call [135]/VONT | - | - | 135,000 | call | BioNTech SE (ADRs) | - | 61,260 % | 0,077 | -0,017 | 9,999 | 18.09.2026 | 0,100 | Vontobel | |
| VY2CYF | | BioNTech SE (ADRs)/OS/Call [135]/VONT | - | - | 135,000 | call | BioNTech SE (ADRs) | - | 48,850 % | 0,154 | -0,015 | 7,018 | 18.12.2026 | 0,100 | Vontobel | |
| BD1QD1 | | BioNTech SE (ADRs)/OS/Call [135]/VONT | - | - | 135,000 | call | BioNTech SE (ADRs) | - | - | - | - | - | 19.03.2027 | 0,100 | Vontobel | |
| GW1SE2 | BioNTech SE (ADRs)/OS/Call [136]/GOLDS | - | - | 136,000 | call | BioNTech SE (ADRs) | - | 56,716 % | 0,402 | -0,018 | 3,135 | 17.09.2027 | 0,100 | Goldman Sachs | ||
| GW1SEK | BioNTech SE (ADRs)/OS/Call [136]/GOLDS | - | - | 136,000 | call | BioNTech SE (ADRs) | - | 56,638 % | 0,350 | -0,019 | 3,605 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| MK56SA | | BioNTech SE (ADRs)/OS/Call [136]/MS | - | - | 136,000 | call | BioNTech SE (ADRs) | - | 68,012 % | 0,261 | -0,028 | 4,663 | 18.12.2026 | 0,100 | Morgan Stanley | |
| MM8J99 | | BioNTech SE (ADRs)/OS/Call [136]/MS | - | - | 136,000 | call | BioNTech SE (ADRs) | - | 61,981 % | 0,386 | -0,021 | 3,258 | 17.06.2027 | 0,100 | Morgan Stanley | |
| MM8JVP | | BioNTech SE (ADRs)/OS/Call [136]/MS | - | - | 136,000 | call | BioNTech SE (ADRs) | - | 92,065 % | 0,194 | -0,050 | 5,791 | 18.09.2026 | 0,100 | Morgan Stanley | |
| MN0F2Z | | BioNTech SE (ADRs)/OS/Call [136]/MS | - | - | 136,000 | call | BioNTech SE (ADRs) | - | 70,134 % | 0,505 | -0,020 | 2,334 | 17.12.2027 | 0,100 | Morgan Stanley | |
| MN681M | | BioNTech SE (ADRs)/OS/Call [136]/MS | - | - | 136,000 | call | BioNTech SE (ADRs) | - | 63,842 % | 0,334 | -0,024 | 3,764 | 19.03.2027 | 0,100 | Morgan Stanley | |
| MR34X9 | | BioNTech SE (ADRs)/OS/Call [136]/MS | - | - | 136,000 | call | BioNTech SE (ADRs) | - | 82,904 % | 0,616 | -0,019 | 1,789 | 16.06.2028 | 0,100 | Morgan Stanley | |
| UP9B0D | BioNTech SE (ADRs)/OS/Call [136]/UBS | - | - | 136,000 | call | BioNTech SE (ADRs) | - | - | - | - | - | 18.12.2026 | 0,100 | UBS | ||
| GW1SEJ | BioNTech SE (ADRs)/OS/Call [138]/GOLDS | - | - | 138,000 | call | BioNTech SE (ADRs) | - | 56,615 % | 0,340 | -0,019 | 3,641 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| GW1SGE | BioNTech SE (ADRs)/OS/Call [138]/GOLDS | - | - | 138,000 | call | BioNTech SE (ADRs) | - | 55,867 % | 0,382 | -0,017 | 3,229 | 17.09.2027 | 0,100 | Goldman Sachs |